A Biotech Founder Makes the Moral Case for Gene-Editing Human Embryos
The practice of editing the genes of embryos remains highly controversial and risky, but Origin Genomics founder Cathy Tie argues its a “moral imperative” to address hereditary diseases.
Cathy Tie, a biotech entrepreneur and founder of Origin Genomics, is advocating for gene-editing of human embryos, arguing it is a "moral imperative." Origin Genomics plans to bring gene-edited embryos to IVF clinics. However, questions remain about the safety of gene-edited embryos and the risks for resulting children. Germ-line gene editing involves modifying cells involved in reproduction, which could be passed to future generations.
Any changes could introduce new health risks or correct devastating genetic mutations. While many countries have banned gene-editing of human embryos for pregnancy, critics argue that IVF screening tools make embryo editing unnecessary. Gene editing could provide more chances at a future family for couples at risk of passing on genetic diseases, like Ian Watts and Cheyenne Ziegler, who have undergone multiple rounds of IVF with limited success.
Tie believes the technology is close enough to be developed for human use, but additional research is needed to assess embryos in the lab and follow several generations to ensure no unexpected changes occur.
Written by urgent.news from Wired's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
